ALPHA TEKNOVA, INC. SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net
ALPHA TEKNOVA, INC. (TKNO) had SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net of 7.49% as of 2025-07-31, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › SEC Schedule
us-gaap:PremiumsPercentageAssumedToNet · last filed 2025-11-07
- 2025-07-31: SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net 7.49%.
- 2025-07-08: SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net 7.49%.
| Period end | SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net |
|---|---|
| 2025-07-31 | 7.49% 10-Q · filed 2025-11-07 |
| 2025-07-08 | 7.49% 10-Q · filed 2025-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |